Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$11.26M+162%$6.71M-28.4%$2.83M-84.2%$3.66M-83.5%$4.3M-79.7%
$6.88M+31.5%$3.77M-39.2%$4.05M-46.5%$3.63M-38.2%$5.23M-18.9%
$17.21M+80.5%$78.57M+405%$6.87M-76.8%$7.29M-74.0%$9.54M-65.6%
-$17.21M-80.5%-$78.57M-405%-$6.87M+76.8%-$7.29M+74.0%-$9.54M+65.6%
$586K+49.1%$255K-54.7%$263K-70.1%$325K-72.2%$393K-70.9%
-$32.95M-260%-$82.89M-452%-$6.61M+77.0%-$6.97M+74.1%-$9.14M+65.3%
-$1.73+26.1%-$18.90-390%-$1.68+77.5%-$0.18+74.3%-$2.34-239%
-$16.98M-82.8%-$78.32M-411%-$6.67M+77.3%-$7.09M+74.5%-$9.29M+66.1%
-$17.21M-80.5%-$78.57M-405%-$6.87M+76.8%-$7.29M+74.0%-$9.54M+65.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is LeonaBio, Inc. Common Stock profitable?
LeonaBio, Inc. Common Stock is not currently profitable: it reported a net loss of $129.4M over the trailing twelve months.
What is LeonaBio, Inc. Common Stock's earnings per share?
LeonaBio, Inc. Common Stock's diluted EPS over the trailing twelve months is $-22.49.
Where does LeonaBio, Inc. Common Stock's income statement data come from?
Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.